Results 241 to 250 of about 37,410 (291)

The Role of Artificial Intelligence in Theranostics. [PDF]

J Nucl Med Technol
Currie GM, Rohren E.
europepmc   +1 more source

Questing for Integrin Targeting Theranostics for Cancer Cell-Selective Molecules. [PDF]

ACS Omega
Giraldi V, Pecoraro T, Maurizio A, Milana A, De Cola L, Baiula M, Giacomini D.   +6 more
europepmc   +1 more source

Publisher Correction: CFTR mediates Cl^- transport in osteocytes to sustain cell viability and skeletal homeostasis. [PDF]

Nat Commun
Hu P, Du W, Chu M, Chen J, Zhang X, Chen Z, Hu J, Qin L, Lee WY, Guo J, Chen H, Xu R, Cai X, Jiang X, Chan HC, Qin L, Xu J, Ruan YC.   +17 more
europepmc   +1 more source

Emerging Nanotherapy Applications in Cancer Treatment: <i>A Comprehensive Review</i>. [PDF]

Saudi Med J
Mahallawi WH.
europepmc   +1 more source

Science and technology in nuclear medicine: historical perspective and update on current developments - an extended essay. [PDF]

Z Med Phys
Schober O.
europepmc   +1 more source

Matched Pair Theranostics.

Chimia, 2019
openaire   +2 more sources

Clinical Perspectives of Theranostics [PDF]

Molecules, 2021
Theranostics covers combination of diagnostic and therapeutic techniques for various cancers throughout body using suitable drug combination. This review covers well-known treatment of thyroid cancer and pheochromocytoma with I-131 compounds and also new radiopharmaceuticals for prostatic cancer and pancreatic cancer.
Nagara Tamaki, Tohru Shiga, Shozo Okamoto   +2 more
exaly   +7 more sources

Some of the next articles are maybe not open access.

Related searches:

Theranostics in Neuroblastoma

PET Clinics, 2021
Theranostics combines diagnosis and targeted therapy, achieved by the use of the same or similar molecules labeled with different radiopharmaceuticals or identical with different dosages. One of the best examples is the use of metaiodobenzylguanidine (MIBG). In the management of neuroblastoma-the most common extracranial solid tumor in children.
Margarida Simao, Rafael, Sarah, Cohen-Gogo, Meredith S, Irwin, Reza, Vali, Amer, Shammas, Daniel A, Morgenstern   +5 more
openaire   +2 more sources

Theranostic Nanomedicine

Accounts of Chemical Research, 2011
Nanomedicine formulations aim to improve the biodistribution and the target site accumulation of systemically administered (chemo)therapeutic agents. Many different types of nanomedicines have been evaluated over the years, including for instance liposomes, polymers, micelles and antibodies, and a significant amount of evidence has been obtained ...
Xiaoyuan, Chen, Sanjiv S, Gambhir, Jinwoo, Cheon   +2 more
openaire   +6 more sources